EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes

The Efficacy of Topical Thiocolchicoside in Cervical Myofascial Pain Syndrome: Triple-Arm, Single-Blind, Randomized, Prospective, Phase IV Clinical Study

NCT00272532•Sanofi

View on ClinicalTrials.gov

Summary

Study objective: * To demonstrate, in patients with myofascial pain syndrome in cervical region, the degree of efficacy of thiocolchicoside ointment administered to trigger point regions compared with the trigger point injection.

Eligibility

Age

18 - 50 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Submitted to clinic with a complaint of head and neck pain
•Be diagnosed as having myofascial pain syndrome by determining the active trigger points in trapezius and/or interscapular region according to criteria of Simons and Travel
•Have 1 to 8 active trigger point(s)

Exclusion Criteria

•Have evident cervical discopathy and signs of osteoarthritis
•Have bleeding diathesis or using anticoagulant medication which hinders injection
•Have known malignity, being used steroids, have immunodepressive disorders and/or being taken immunodepressive drugs
•Be pregnant or have the possibility of being pregnant or not being used a regular contraceptive method
•Have known allergic reaction against Thiocolchicoside

Locations (1)

Sanofi-Aventis

Istanbul, Turkey (Türkiye)

Key Dates

Start Date

April 1, 2005

Last Updated

February 20, 2008

Enrollment

Estimated participants

Conditions

Myofascial Pain Syndromes

Interventions

Thiocolchicoside

DRUG

Comparative Effect of MEP With or Without Current Emission in the Treatment of Cervical Pain in MTrPs of the Trapezius

NCT05524623

Neck Pain, PosteriorMyofascial Pain Syndromes

View study

COMPLETEDPHASE2

Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points

NCT01106989

Myofascial Pain Syndromes

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2008Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions